BT-20 Cells
USD$395.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The BT-20 cell line is a human breast adenocarcinoma cell line that was established in 1958 from the malignant tissue of a 74-year-old Caucasian female patient. This cell line exhibits epithelial-like morphology and is often used in research focused on breast cancer biology, particularly in studies exploring the hormonal regulation of cancer growth, gene expression, and the efficacy of therapeutic agents against breast cancer. BT-20 cells are characterized by their ability to form tumors when implanted in immunocompromised mice, thus serving as a useful in vivo model for breast cancer. These cells express receptors for estrogen, progesterone, and androgen, making them relevant for studies on hormone response pathways. Additionally, genetic analysis of BT-20 cells has revealed mutations in genes such as TP53 and PIK3CA, which are common in breast cancer, supporting their use in genetic and pharmacological research. In vitro, BT-20 cells are used to study the mechanisms of cancer cell proliferation, migration, and invasion. They are also employed to assess the cytotoxicity of chemotherapy agents, making them critical for preclinical testing of anti-cancer drugs. The adaptability of BT-20 cells to various culture conditions and their robust growth in vitro make them a valuable resource for cancer research laboratories focusing on the underlying mechanisms of breast cancer and the development of new therapeutic strategies. |
|---|---|
| Organism | Human |
| Tissue | Breast, mammary gland |
| Disease | Invasive ductal carcinoma |
| Synonyms | BT 20, BT20 |
Characteristics
| Age | 74 years |
|---|---|
| Gender | Female |
| Ethnicity | Caucasian |
| Morphology | Epithelial-like |
| Growth properties | Monolayer, adherent |
Regulatory Data
| Citation | BT-20 (Cytion catalog number 300130) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_0178 |
Biomolecular Data
| Antigen expression | HLA A1, Bw16 (+/-) |
|---|---|
| Isoenzymes | PGM3, 1, PGM1, 1, ES-D, 1, AK-1, 1-2, G6PD, B, GLO-1, 1-2, Phenotype Frequency Product: 0.0115 |
| Oncogenes | Wnt4 +, wnt7h + |
| Tumorigenic | Yes, in nude mice. Forms grade II adenocarcinomas |
| Reverse transcriptase | Negative |
| Mutational profile | TP53 mut |
| Karyotype | Modal number = 50, many markers with large subtelocentrics most characteristic. (P87) Hyperdiploid with abnormalities including fragmented chromosomes, breaks, secondary constrictions, translocations, submetacentric and telocentric markers |
Handling
| Culture Medium | DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 2.5 mM L-Glutamine, w: 15 mM HEPES, w: 0.5 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Seeding density | 1 x 104 cells/cm2 will yield in a confluent layer in about 6 days |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 300130-220525 | Certificate of Analysis | 21. Jul. 2025 | 300130 |
| 300130-1120SF | Certificate of Analysis | 23. May. 2025 | 300130 |